WebDec 7, 2024 · Dec 7 (Reuters) - Private equity firm Veritas Capital is exploring a sale of Cotiviti Corp that could secure a valuation of over $15 billion for the healthcare analytics … WebApr 12, 2024 · Veritas Capital ended talks with Carlyle Group Inc CG to buy a 50% stake in private healthcare technology firm Cotiviti Inc on valuation grounds, a source familiar …
Veritas, Carlyle end talks on Cotiviti stake sale - source
WebThe transaction was announced on June 19, 2024, and received approval from Cotitivi shareholders on August 24, 2024. As a result of the completion of the transaction, shares of Cotiviti common stock were removed from listing on the New York Stock Exchange (“NYSE”), with trading in Cotiviti shares suspended prior to the opening of business ... Web2 days ago · Scrapped: Carlyle Group dropped plans to invest in healthcare analytics company Cotiviti after lining up $5.5 billion in debt and another $1 billion preferred stock to finance the deal, Financial ... rite aid pharmacy west bay traverse city
Private equity firm Veritas weighs sale of Cotiviti - Nasdaq
Web2 days ago · In February, Reuters reported that Carlyle was in talks to buy a portion of Cotiviti from Veritas Capital at a valuation of around $15 billion. Cotiviti, which went public in 2016, was acquired by Veritas in 2024 in a take-private deal valued at $4.9 billion, as the private equity firm looked to expand its Verscend healthcare IT business. WebApr 11, 2024 · Cotiviti, which went public in 2016, was acquired by Veritas in 2024 in a take-private deal valued at $4.9 billion, as the private equity firm looked to expand its Verscend healthcare IT business. WebAug 27, 2024 · Under the terms of the agreement, Cotiviti shareholders will receive merger consideration in the amount of $44.75 in cash for each share of Cotiviti common stock they hold (without interest and subject to any applicable withholding taxes or other amounts required to be withheld therefrom under applicable law). smith and warren design a badge